Summary Pentoxifylline (PTX) has been shown to increase radiation damage to tumours and to decrease late radiation-induced injury to normal tissues. This tumour radiation sensitisation results from increased oxygen supply via improved tumour perfusion. We propose that the improved perfusion results from decreased viscous resistance and/or geometric resistance. The 
The original studies of Dion et al. (1989 Dion et al. ( , 1990 demonstrated that in the post-irradiation period multiple injections of pentoxifylline (PTX) can decrease late radiation-induced injury to normal tissue as a result of an improved blood supply. PTX has also been shown to be a radiation sensitiser (Lee & Cho, 1991; Lee et al., 1992a Lee et al., , 1993 . Single or multiple doses of 100 mg kg-' PTX can increase the radiation-induced tumour growth delay as well as local control of FSaII murine tumours. Recently, Song et al. (1992) found an increased P02 20-50 min following PTX treatment (5 or 50 mg kg-' in a single dose) in FSaII tumours. The increased PO2 in tumours results from reduced oxygen consumption (Gullino, 1975; Vaupel et al., 1987) and/or increased oxygen availability through modifications in tumour blood flow (TBF) (Coleman, 1988) . While there are no direct measurements of in vivo oxygen consumption following PTX treatment, Lee et al. (1993) have shown that single injection of PTX does not increase the RBC flux in the periphery of FSaII tumours using the laser Doppler surface probe. Therefore, there are ambiguous results upon single administration of various dosages of PTX. In this study we focused on single injection of PTX. We measured intra-tumour P02 in control and PTX (25 and 100 mg kg-')-treated groups. We also measured the RBC flux in the periphery and centre of FSaII tumours with a standard surface probe as well as a needle probe using laser Doppler flowmetry to determine if the increased oxygenation with PTX was due to a greater oxygen availability. Furthermore, similar to our recent study with nicotinamide (Lee et al., 1992b) , we hypothesised that if PTX can decrease resistance to blood flow it could also lower tumour hypertension. Therefore, we measured tumour interstitial fluid pressure (TIFP) using the wick-in-needle method (WIN (Lee et al., 1992b) . Experiments for the measurement of physiological parameters such as RBC flux, P02, TIFP and mean arterial blood pressure (MABP) were carried out when tumour volume reached -250mm3.
Pentoxifylline (PTX) treatment Pentoxifylline (PTX), a derivative of methyl xanthine, 3,7-dimethyl-1-(5-oxyhexyl) xanthine, was dissolved in sterile saline before the experiments. The mice were given an i.p. injection of two different dosages of PTX (25 or 100 mg kg-') in a volume of 0.01 ml per g of body weight. Dezube et al. (1990) have calculated the conversion factor between mice and humans for PTX using Freireich's quantitative interspecies comparison (Freireich et al., 1966) with glass and mounted in a 27 gauge needle. The sensor electrode is gold plated on platinum wire and protected by an oxygen-permeable membrane (oxygen sensitivity is -7 x 10-'2 amp mmHg-' 02). The temperature of the P02 calibration solutions was maintained at --34°C using a calibration cell mounted in a water bath (General Diamond), and the electrodes were calibrated by immersing them in a series of isotonic saline solution saturated with four different known oxygen levels (0%, 5%, 10% and 20% oxygen). In each tumour 25-50 measurements were made, and the data were recorded by a Mac Lab/4 analogue-to-digital system (ADInstruments, Castle Hill, New South Wales, Australia) linked to a Macintosh computer. P02 was measured at 20-50min following the injection of 25mgkg-' PTX. Following the observation that RBC flux was not modified with a PTX dose of 25 mg kg-', but was significantly increased in less than O min and remained elevated for a period of at least 90 min at a dose of 100 mg kg-', we decided to measure P02 over a period of 60-90 min following the injection of PTX. It is known that electrode signal shifts with time; therefore, we measured P02 over an -30 min period, and we then compared the calibration values before and after measurements of P02 to confirm whether the measured oxygen values were acceptable. The P02 values were discarded when the calibration values shifted by more than 2% in 30 min (Lee et al., 1990 ).
Measurements of relative TBF (laser Dopplerflow; LDF)
Relative TBF (RBC flux) was measured using the Laserflow Blood Perfusion Monitor 403A (TSI, St. Paul, MN, USA). For the application of a laser Doppler surface probe, a probe was placed on the tumour surface after the skin was removed . In a different group of animals, a small hole was made in the tumour using a 23 gauge needle and a 0.8-mm-diameter laser Doppler needle probe was inserted in the tumour centre, and then slightly withdrawn to ensure that there was no compression of the tumour under the probe tip. The electrical signal of flow, velocity and volume from the laser Doppler systems were digitally processed using the Mac Lab/4 analogue-to-digital system (ADInstruments) linked to a Macintosh computer with output voltage ranging from 0 V to 2.5 V. RBC flux was monitored for a period of 90 min following the injection of PTX. In addition, the zeroflow signal was measured at the end of the experiments by sacrificing the animals with an overdosage of anaesthesia; the biological zero-flow signal was well above electrical zero (output signals were usually between --, 25 mV and -150 mV in dead animals).
Measurement of mean arterial blood pressure (MABP) and tumour interstitial fluid pressure (TIFP) The right carotid artery was cannulated with a PE-10 polyethylene catheter, as previously described (Lee et al., 1992b) . TIFP was measured with the WIN technique (Fadnes et al., 1977; Boucher et al., 1991; Lee et al., 1992b) . In brief, a 23 gauge needle with a side-hole -~-3 mm from the tip was filled with five nylon surgical sutures (6-0 Ethilon; Ethicon, Somerville, NJ, USA). The needle was connected to a pressure transducer by PE-50 polyethylene tubing filled with sterile heparinised (70 units ml-') saline. Before pressure measurements in each animal, the calibration of the pressure transducer set-up was verified by applying pressures of 0, 5, 15 and 30 cm of saline. TIFP was measured continuously in the centre of tumours with one needle before and for 4 h following the injection of PTX.
Data analysis All values except P02 are shown as mean ± standard error (s.e.) of each group and time points for the parametric statistic. Percentage changes were determined individually for each mouse, based on pretreatment values, and then averaged. Significant differences within a group before and after PTX treatment were evaluated using a paired t-test, and between treatment groups with an unpaired t-test. Tumour P02 histograms were tested for significant difference in median values for two independent samples using a Utest.
Results
PTX at a dose of 25 mg kg-' did not improve tumour oxygenation significantly, although Po2 values below 5 mmHg decreased from 65 to 56% (data not shown). However, the PTX dose of 100mgkg-' increased median P02 from 5 to 7 mmHg (P <0.05). Intra-tumour P02 values below 5mmHg significantly decreased (P<0.05) from 65 to 45% (Figure la and b) . The improved tumour oxygenation at a PTX dose of 100mgkg-' was associated with a statistically significant increase in RBC flux in the centre of tumours (n = 6, P <0.05). The increase in RBC flux was significant at 5 and 10min post treatment, and remained at that level (-1.3-fold) for at least 90 min (Figure 2) . In a few animals, RBC flux was monitored up to 4 h, and it remained elevated for 4 h (data not shown). However, when the standard surface probe was used, RBC flux in the tumour periphery was not modified (data not shown). No differences in the RBC flux in the periphery or centre of tumours were found at a PTX dose of 25 mg kg' as well as in the saline-treated animals. Figure 3 shows changes in MABP and TIFP as a function of time after an i.p. injection of 100 mg kg-' PTX (n = 13 (Wheatley et al., 1993) .
Therefore, it is reasonable to conclude that there was no the tumour difference in the response between RBC flux and intratumour P02. Tumour blood flow (TBF) is proportional to arterial minus venous pressure (AP) and inversely proportional to flow resistance (Jain, 1988) . Since PTX did not modify MABP, it is quite likely that the principal effect of PTX was on flow resistance. PTX has been shown to decrease WBC and RBC rigidity (Muller, 1981; Dettelbach & Aviado, 1985; Ward & Clissold, 1987) , reduce platelet aggregation (Ambrus et al., 1979) as well as reduce fibrinogen levels (Jarret et al., 1977) . By exerting a rheological effect on blood cells PTX could reduce viscous resistance and thus increase tumour perfusion.
Reduced TBF during tumour growth has been attributed in part to vessel collapse. Some investigators have postulated that the vascular collapse results from higher hydrostatic pressure in the interstitial space compared with the microvas-100 cular space (Paskins-Hurlburt et al., 1982; Wiig, 1982) . TBF increased rapidly and reached plateau levels 10 min after the injection of PTX (Figure 2 ), whereas TIFP was still decreasing up to 120 min following the injection of PTX (Figure 3 (Jain, 1987; Boucher inistration of et al., 1990 Boucher inistration of et al., , 1991 Roh et al., 1991; Gutmann et al., 1992; Lee et al., 1992b; Less et al., 1992) . It is also believed to be a major obstacle to the delivery of macromolecules (Jain, 1987 (Jain, , 1989 Jain & Baxter, 1988) . Therefore, the second goal of this 1.5 study was to lower TIFP using PTX. TIFP is governed predominantly by the local MVP and F the hydraulic conductivity of the interstitial compartment .C (Baxter & Jain, 1989 (Zlotecki et al., 1993 *In preliminary studies we found that TIFP also decreased in larger tumours (between -350mm3 and -600 mm3).
fraction of the TIFP drop could be attributed to the MABP decrease (Lee et al., 1992b) . Furthermore, the decrease in flow resistance caused by nicotinamide can also lead to increased TBF and decreased TIFP (Lee et al., 1992b) . PTX, on the other hand, has no effect on MABP. How then can TBF go up and TIFP go down? We hypothesise that PTX lowers the viscous resistance to blood flow, and hence increases TBF. The decrease in viscous resistance also leads to a lower MVP, which results in lower TIFP. Song et al. (1992) reported that the increase in P02 in FSaII tumours after 5 mg kg-' PTX varied between -2 and 7 mmHg, peaking at 20-50 min post treatment, and then declining to the original value. In the present study, following a PTX dose of 25 mg kg-' tumour oxygenation was not improved at 20-50min post treatment (data not shown). One possible reason for the discrepancy between the two studies is as follows. In the work by Song et al. (1992) , P02 modifications induced by PTX were measured continuously at a single position in the tumour. A single measurement per tumour may not represent an increased oxygenation throughout the tumour. Therefore, our study supports the mechanism that radiosensitisation in vivo by PTX may be due to increased oxygen availability in tumours, and thus enhanced tumour oxygenation.
In conclusion, the increase in tumour oxygenation and relative TBF (RBC flux) by PTX at 100 mg kg-' was significant; however, we failed to show the same effect at a dosage of 25 mg kg-' PTX. PTX at 100 mg kg-' can increase oxygen availability in the tumour as a result of temporary increases in RBC flux in the tumour centre, and thus ameliorate hypoxia in tumour microregions. Also, PTX at 100 mg kg' can significantly lower the elevated TIFP without lowering the MABP.
